Viatris Inc. (VTRS) Financials
VTRS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 48.7 billion | 27.9 billion |
| 2023-06-30 | 48.7 billion | 27.9 billion |
| 2023-03-31 | 49.3 billion | 28.4 billion |
| 2022-12-31 | 50.0 billion | 28.9 billion |
VTRS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | 732.0 million | 43.1 million |
| 2023-06-30 | 425.9 million | 39.2 million |
| 2023-03-31 | 888.7 million | 42.6 million |
| 2022-12-31 | -23.3 million | 29.6 million |
VTRS Net Income
| Date | Net Income |
|---|---|
| 2023-09-30 | 331.6 million |
| 2023-06-30 | 264.0 million |
| 2023-03-31 | 224.7 million |
| 2022-12-31 | 1.0 billion |
VTRS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 1.3 billion | - | 248.9 million |
| 2023-06-30 | 629.2 million | 17.2 billion | 252.2 million |
| 2023-03-31 | 506.6 million | 18.1 billion | 256.7 million |
| 2022-12-31 | 1.3 billion | - | 262.0 million |
VTRS Shares Outstanding
VTRS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 102.1 million | 211.2 million | 1.1 billion | - |
| 2023-06-30 | 89.0 million | 208.3 million | 1.0 billion | - |
| 2023-03-31 | 82.5 million | 182.9 million | 958.9 million | - |
| 2022-12-31 | 165.9 million | 182.4 million | 1.3 billion | - |
VTRS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 3.9 billion | 2.3 billion |
| 2023-06-30 | 3.9 billion | 2.3 billion |
| 2023-03-31 | 3.7 billion | 2.2 billion |
| 2022-12-31 | 3.9 billion | 2.6 billion |
VTRS
Price: $11.78
Dividend Yield: 0.04%
Forward Dividend Yield: 4.15%
Payout Ratio: 31.79%
Dividend Per Share: 0.48 USD
Earnings Per Share: 0.05 USD
P/E Ratio: 7.74
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 6.2 million
Market Capitalization: 13.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 4